ClinConnect ClinConnect Logo
Search / Trial NCT02558907

Comparison of MMSE (Mini-Mental State Examination) and MoCA (Montreal Cognitive Assessment) in Cognitive Assessment in Geriatric Oncology

Launched by CENTRE FRANCOIS BACLESSE · Sep 23, 2015

Trial Information

Current as of August 28, 2025

Completed

Keywords

Geriatrics Cancer Mms Test Mo Ca Test Cognitive Evaluation

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patient old over 70 years
  • Patient with cancer (solid tumor or hematological) for which a 1st line treatment is planned
  • Patient candidate an oncogeriatric assessment
  • Patient agreeing to participate in the study
  • French language
  • Lack of subsequent neurological sequelae with cognitive impact stroke, dementia or progressive psychiatric disorder
  • Patient having a life expectancy ≥ 6 months
  • Exclusion Criteria:
  • Primitive cancer of the central nervous system or brain metastasis
  • Patients unable to meet the cognitive tests
  • Refusal to participate
  • Realization of a MMSE or MoCA test in the last 6 months

About Centre Francois Baclesse

The Centre François Baclesse is a leading cancer research and treatment facility in France, dedicated to advancing oncology through innovative clinical trials and cutting-edge medical care. Renowned for its multidisciplinary approach, the center integrates comprehensive patient management with pioneering research initiatives, focusing on developing new therapies and improving existing treatments for various cancer types. With a commitment to enhancing patient outcomes, the Centre François Baclesse collaborates with national and international partners to contribute to the global body of knowledge in cancer treatment and research, making it a pivotal player in the fight against cancer.

Locations

Caen, , France

Caen, , France

Patients applied

0 patients applied

Trial Officials

Heidi LAVIEC, MD

Principal Investigator

Centre François Baclesse - CAEN

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials